Form 4 for PG Procter & Gamble
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-24 · accession 0001127602-23-013505 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-25 | 2023-04-24 | PG | Davis Jennifer L. | CEO - Health Care | S - Sale+OE | $155.27 | -23.9K | 39.9K | -38% | -$3.72M |
| D | 2023-04-25 | 2023-04-24 | PG | Davis Jennifer L. | CEO - Health Care | M - OptEx | $78.52 | +23.9K | 63.8K | +60% | +$1.88M |
| D | 2023-04-25 | 2023-02-15 | PG | Davis Jennifer L. | CEO - Health Care | A - Grant | $0.00 | +13.19 | 43.12 | +44% | $0 |
| D | 2023-04-25 | 2023-04-24 | PG | Davis Jennifer L. | CEO - Health Care | M - OptEx | $0.00 | -23.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-24 | S | D | 23,943 | $155.27 | 39,860.35 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-24 | M | A | 23,943 | $78.52 | 63,803.35 | D | — | — | (F1) Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| 3 | Derivative | Restricted Stock Units | 2023-02-15 | A | A | 13.19 | $0.00 | 43.12 | D | — · — to — | 13.19 Common Stock | (F3) Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. (F4) These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| 4 | Derivative | Stock Option (Right to Buy) | 2023-04-24 | M | D | 23,943 | $0.00 | 0 | D | $78.52 · 2021-02-26 to 2028-02-28 | 23,943 Common Stock |